Cardiovascular proteomics is a specialized branch of proteomics that focuses on the comprehensive study of proteins involved in cardiovascular health and disease. Proteomics, the large-scale analysis of proteins, plays a crucial role in unraveling the complex molecular mechanisms underlying cardiovascular conditions such as heart disease and stroke. By examining the complete set of proteins present in the cardiovascular system, researchers aim to identify biomarkers for early disease detection, understand the pathways involved in disease progression, and discover potential therapeutic targets. The application of advanced mass spectrometry and other high-throughput technologies enables the systematic analysis of protein expression, post-translational modifications, and interactions within the intricate network of proteins associated with the cardiovascular system. The insights gained from cardiovascular proteomics not only deepen our understanding of the molecular basis of cardiovascular diseases but also pave the way for the development of innovative diagnostic tools and targeted therapies, ultimately contributing to improved patient outcomes in the realm of cardiovascular health.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain